Do Quality-Adjusted-Life-Year-Based Cost-Effectiveness Analyses Discriminate Against Disabled Patients? A Theoretical and Empirical Analysis.

Saved in:
Bibliographic Details
Title: Do Quality-Adjusted-Life-Year-Based Cost-Effectiveness Analyses Discriminate Against Disabled Patients? A Theoretical and Empirical Analysis.
Authors: Ma Y; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China; Center for Pharmacoeconomics and Outcome Research, China Pharmaceutical University, Nanjing, China., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA., Vanness DJ; Department of Health Policy and Administration, Pennsylvania State University, University Park, PA, USA., Li H; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China; Center for Pharmacoeconomics and Outcome Research, China Pharmaceutical University, Nanjing, China., Xie F; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; Center for Health Economics and Policy Analysis, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada. Electronic address: fengxie@mcmaster.ca.
Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2026 Sep; Vol. 29 (9), pp. 1580-1589. Date of Electronic Publication: 2026 Apr 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4733
DOI:10.1016/j.jval.2026.04.005